Original Publication
Open Access

Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: Team-Based Learning

Published: September 28, 2015 | 10.15766/mep_2374-8265.10222

Included in this publication:

  • Instructor's Guide.docx
  • Lipids Application Exercise.docx
  • Lipids RAT.docx
  • Lipids Pre-Session Document.docx

To view all publication components, extract (i.e., unzip) them from the downloaded .zip file.


Editor's Note: This publication predates our implementation of the Educational Summary Report in 2016 and thus displays a different format than newer publications.

Abstract

Introduction: This is one of seven biannual team-based learning (TBL) modules used in the clinical pharmacology course that is offered to third-year medical students at the American University of Beirut Faculty of Medicine. The clinical pharmacology course was initiated in 2008 when it was first offered to fourth-year medical students, and then it was gradually moved to third-year medical students. The main objective of the course is to apply rational prescribing within several clinical case scenarios. In this resource the treatment of dyslipidemia is explored. The remaining six modules explore the treatment of Type 2 Diabetes, treatment of hypertension, treatment of chronic obstructive disease, prophylaxis of venous thromboembolism in medical patients, pain management, and treatment of community acquired pneumonia. Methods: The prereading material typically includes an article from The Medical Letter journal and a summary of the treatment guidelines from the relevant associations or expert groups. Students then engage in an individual readiness assurance test before being grouped into teams where they complete a group readiness assurance test and a series of team application exercises. Results: Two articles describing the course and its outcome have been recently published. We have shown that medical students were highly satisfied with the course and the teaching approach and that their performance on prescription writing and formulary development had improved. Discussion: The original dyslipidemia session has been deployed more than 10 times. However, with the recent guidelines, the case has been modified and reformatted, and the readiness assurance test questions formulated de novo. This new session has so far been delivered three times.


Educational Objectives

By the end of this session, learners will be able to:

  1. Identify patients most likely to benefit from cholesterol-lowering statin therapy.
  2. Outline an effective treatment plan for patients with high low-density lipoprotein levels with or without clinical atherosclerotic cardiovascular disease, based on their risk factors and in line with the latest guidelines for lipid management.
  3. Design an appropriate monitoring plan for a patient receiving statin therapy including clinical and laboratory parameters and time intervals for follow-up.
  4. Demonstrate the ability to communicate and work effectively in a small group.
  5. Write a prescription.

Author Information

  • Asma Arabi, MD, MSc: American University of Beirut
  • Mona P. Nasrallah, MD: American University of Beirut
  • Nathalie K. Zgheib, MD: American University of Beirut

Disclosures
None to report.

Funding/Support
None to report.


References

  1. Bou Akl I, Ghaddar F, Sabra R, et al. Teaching clinical pharmacology using team-based learning: a comparison between third- and fourth-year medical students. J Clin Pharmacol. 2012;52(12):1806-1814. http://dx.doi.org/10.1177/0091270011428986
  2. Zgheib NK, Simaan JA, Sabra R. Using team based learning to teach clinical pharmacology in medical school: student satisfaction and improved performance. J Clin Pharmacol. 2011;51(7):1101-1111. http://dx.doi.org/10.1177/0091270010375428



Citation

Arabi A, Nasrallah M, Zgheib N. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: team-based learning. MedEdPORTAL. 2015;11:10222. https://doi.org/10.15766/mep_2374-8265.10222